Squarepoint
GH icon

Squarepoint’s Guardant Health GH Stock Holding History

Squarepoint’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$87M Buy
580,133
+388,393
+203% +$42.2M 0.1% 199
2026
Q1 		$17.7M Buy
191,740
+54,846
+40% +$5.51M 0.02% 776
2025
Q4 		$14M Buy
+136,894
New +$12.2M 0.01% 918
2025
Q3 		– Sell
-7,328
Closed -$399K – 4578
2025
Q2 		$381K Buy
7,328
+2,000
+38% +$89.3K ﹤0.01% 3507
2025
Q1 		$227K Buy
+5,328
New +$230K ﹤0.01% 3929
2024
Q3 		– Sell
-19,592
Closed -$566K – 4310
2024
Q2 		$566K Sell
19,592
-695,720
-97% -$16.2M ﹤0.01% 2987
2024
Q1 		$14.8M Buy
715,312
+342,269
+92% +$7.34M 0.03% 767
2023
Q4 		$10.1M Buy
373,043
+360,373
+2,844% +$9.45M 0.02% 945
2023
Q3 		$376K Buy
+12,670
New +$446K ﹤0.01% 2997
2023
Q2 		– Sell
-260,035
Closed -$6.1M – 3716
2023
Q1 		$6.1M Buy
+260,035
New +$7.43M 0.02% 769
2022
Q4 		– Sell
-12,376
Closed -$666K – 3329
2022
Q3 		$666K Sell
12,376
-135,549
-92% -$6.96M ﹤0.01% 2047
2022
Q2 		$5.97M Buy
+147,925
New +$7.33M 0.03% 594
2021
Q2 		– Sell
-28,123
Closed -$3.78M – 3397
2021
Q1 		$4.29M Buy
28,123
+22,769
+425% +$3.44M 0.03% 694
2020
Q4 		$690K Sell
5,354
-21,994
-80% -$2.53M 0.01% 1576
2020
Q3 		$3.06M Buy
27,348
+14,880
+119% +$1.36M 0.04% 510
2020
Q2 		$1.01M Buy
+12,468
New +$1M 0.02% 937
2019
Q4 		– Sell
-18,751
Closed -$1.2M – 2597
2019
Q3 		$1.2M Buy
18,751
+14,893
+386% +$1.31M 0.01% 1102
2019
Q2 		$333K Buy
+3,858
New +$295K ﹤0.01% 1890

Other funds holding GH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Squarepoint's GH Position: Q2 2026 in Review

Squarepoint increased its Guardant Health (GH) stake by 203% in Q2 2026, buying an estimated $42.2M and bringing the position to 580,133 shares worth $87M. The position accounts for 0.1% of the portfolio, ranked #199.

Squarepoint first reported a position in GH in Q2 2019 and has held it in 18 quarters since. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Squarepoint held 580,133 shares of Guardant Health worth $87M as of Q2 2026.
  • Squarepoint bought 388,393 Guardant Health shares in Q2 2026, an estimated $42.2M.
  • Guardant Health made up 0.1% of Squarepoint's portfolio in Q2 2026, its #199 holding.
  • Squarepoint first reported a position in Guardant Health in Q2 2019 and has held it in 18 quarters since.
  • 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.